PUNE, India, December 21, 2015 /PRNewswire/ --
One of the major trends in Left Atrial Appendage (LAA) Closure Market is the increasing focus on clinical trials by vendors for new product launches in the untapped market such as the US and APAC. This factor propels the growth of the market during the forecast period. The increase in awareness programs and significant growth opportunity in the US are also expected to boost market growth in the future.
Complete report on global left atrial appendage (LAA) closure market spread across 87 pages, profiling 4 major companies and supported with 26 data exhibits is now available at is now available at http://www.rnrmarketresearch.com/global-left-atrial-appendage-laa-closure-market-2016-2020-market-report.html .
According to the report, one of the major growth factors is a significant increase in the incidences of stroke. It is estimated that 15 million people worldwide suffer a stroke each year. With the rise in the aging population, excessive smoking, average hypertension, and cholesterol levels, the number of atrial fibrillation cases is also increasing across the globe.
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth - Epicardial LAA closure device and Endocardial LAA closure device. Endocardial involves implantation of a device to occlude the LAA. Endocardial LAA closure devices are implanted through a transseptal approach under TEE technique. A specific delivery system has been developed for each device type allowing for repositioning, collapse, or removal in the event of suboptimal results.
The EMEA region is the highest revenue generator in the left atrial appendage closure market in 2015, accounting for about 52% share, and then followed by the APAC region. The market in the EMEA is expected to continue its growth during the forecast period and this is attributed to increase in the incidence of strokes and the growing elderly population. Stroke alone accounts for 1.1 million deaths in Europe every year. Order a copy of Global Left Atrial Appendage (LAA) Closure Market 2016-2020 report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=443244.
The LAA closure market witness the presence of very few market vendors, hence the competition in the market is moderate at present. However, the competition is expected to intensify with new product launches. Also, there is a vast opportunity for the market to grow significantly in the Americas in the forecast period. The key players in the global left atrial appendage closure market: are AtriCure, Boston Scientific, St. Jude and Coherex Medical. Other Prominent Vendors in the market are: Lifetech Scientific, SentreHEART, and Occlutech.
Further, the report states that one of the major challenges is the complicated LAA closure implantation procedure that requires experienced surgeons. Also, post implantation, timely procedural follow up and medical treatment are needed. This factor restrains the adoption of LAA closure devices.
Explore other new reports on cardiovascular device market at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices/cardiovascular-device .
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
RSS / Feeds: http://www.rnrmarketresearch.com/feed
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
SOURCE RnR Market Research